Table 2 Summary of P-values and OR by phenotype and analysis model for rs6453204
From: Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
Phenotype | Model | Analysis | P -value E5103 a | P -value E2100 b | OR/HR E5103 | OR/HR E2100 |
|---|---|---|---|---|---|---|
SBP>160 | Binary | Additive | 6.0 × 10−8 | NA | 3.3 | NA |
Cumulative dose | Additive | 4.7 × 10−8 | NA | 2.2 | NA | |
Grade 3/4 | Binary | Additive | 3.0 × 10−4 | 0.037 | 2.2 | 2.4 |
Cumulative dose | Additive | 6.4 × 10−5 | 0.091 | 2.0 | 1.9 |